AppLovin: UBS Raises Price Target to $810
UBS hiked AppLovin's stock target to $810, calling it a "top pick". They expect better Axon 2.0 tech and solid advertiser demand.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
UBS hiked AppLovin's stock target to $810, calling it a "top pick". They expect better Axon 2.0 tech and solid advertiser demand.
Federal regulators are easing restrictions on Boeing, allowing the company to resume certain safety checks and potentially boost 737 MAX production following years of strict oversight imposed after safety crises.
Two big banks upgraded Riot Platforms stock. Why? They are moving into AI and high-speed computing which promises huge growth.
Perpetua Resources is seeking major partners like Glencore and Trafigura to build America's capacity to refine antimony—a vital metal needed for solar panels and defense.
KeyBanc downgraded WBD stock, citing high valuation after major year-to-date gains and concerns over demanding acquisition terms surrounding CEO David Zaslav's reported $40/share price target.
President Trump is hitting imports with massive new tariffs starting October 1st, targeting branded drugs (100%), heavy trucks (25%), and furniture.